Artia Global Partners »

Alumis shares owned by Artia Global Partners

Quarter-by-quarter ownership of Alumis (ALMS) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Alumis

Tip: Access up to 7 years of quarterly data

All positions including Alumis held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alumis by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.2M 325k 22.03

More positions owned by Artia Global Partners

Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Eli Lilly & Co. (LLY)
Trevi Therapeutics (TRVI)
Argenx Se Sponsored Adr (ARGX)
Astrazeneca Ord (AZN)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Dianthus Therapeutics (DNTH)
Revolution Medicines (RVMD)
Ionis Pharmaceuticals (IONS)
Moderna Call Option (MRNA)
Eyepoint Com New (EYPT)
Quest Diagnostics Incorporated (DGX)
Alumis (ALMS)
Viking Therapeutics (VKTX)

View all positions for Artia Global Partners

Top funds holding Alumis

AyurMaya Capital Management Company
BlackRock
Deep Track Capital
Samsara BioCapital
Foresite Capital Management V
venBio Partners
Foresite Capital Management VI
Vanguard Group
Vanguard Capital Management
Cormorant Asset Management
Nextech Invest
Saturn V Capital Management
UBS Group
Octagon Capital Advisors
MPM Oncology Impact Management

View all funds holding Alumis